Without changes to lifestyle, weight that took months to shed is rapidly regained once the medication is discontinued, reversing the improvements to metabolic health
Kamada F, Mashimo Y, Inoue H, Shao C, Hirota T, et al: The GSTP1 gene is a susceptibility gene for childhood asthma and the GSTM1 gene is a modifier of the GSTP1 gene
#Type2Diabetes #DiabetesCare #GLP1 #Semaglutide #Tirzepatide #SGLT2Inhibitors #Endocrinology #PharmaMarketIntelligence #MarketResearch #DrugDevelopment #Biopharma #CardiometabolicHealth #HealthcareInnovation #PharmaCommercial To view or add a comment, sign in Kailera Therapeutics Therapeutics has reported positive Phase 3 results for oral GLP-1 candidate KAI-7535 in obesity and type 2 diabetes, although high gastrointestinal event rates remain a major commercial and clinical concern.#KaileraTherapeutics #KAI7535 #GLP1 #ObesityTreatment #Type2Diabetes #ClinicalTrials #Biotechnology #WeightLoss #MetabolicDisease #KLRA To view or add a comment, sign in Tsunami of LDL-lowering drugs, yet a high incidence of vascular plaques and heart attacks is still killing people
[162] 16 12 weeks GLP-1 (SC infusion) vs
Took chemical peeling and Glutathione
